Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33074297.
- Also identified by DOI 10.1001/jamainternmed.2020.4009 and PMC identifier 7573789.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study uses data from the US Provigil/Nuvigil Pregnancy Registry to assess prevalence of fetal major congenital malformations after exposure to modafinil and armodafinil during pregnancy.
Medical subject headings
- Abnormalities, Drug-Induced
- Modafinil
- Wakefulness-Promoting Agents